Kymera Therapeutics Inc. Common Stock vs Unusual Machines Inc. Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Unusual Machines Inc. Common Stock trades at $17.36 (market cap $971.15M). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 9.1× Unusual Machines Inc. Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Unusual Machines Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Unusual Machines Inc. Common Stock for 0 Days on average.
| KYMR | UMAC | |
|---|---|---|
Market Cap | $8.87B | $971.15M |
Volume | 779,107 | 3,714,986 |
Sector | Health | Technology |
52-Week High | $127.31 | $34.06 |
52-Week Low | $55.80 | $7.76 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.26B | $657.94M |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →Unusual Machines Inc. manufactures and sells drone components and complete drones for consumer, enterprise, and defense markets, operating brands including Fat Shark FPV goggles and the Rotor Riot retail platform, with US-based, NDAA-compliant manufacturing.
Read more on UMAC →